Patents/Assignees

Gilead Sciences, Inc.

201 patents in portfolio

US11925631utility2024
Substituted 6-azabenzimidazole Compounds
0 cites
US11926628utility2024
Diacylglyercol Kinase Modulating Compounds
0 cites
US11926645utility2024
Compounds and Methods for Treatment of Viral Infections
0 cites
USD1016608design2024
Pharmaceutical Package
0 cites
US11919869utility2024
CD73 Compounds
0 cites
US11912686utility2024
LPA Receptor Antagonists and Uses Thereof
0 cites
US11903953utility2024
Remdesivir Treatment Methods
0 cites
US11905299utility2024
Cot Modulators and Methods of Use Thereof
0 cites
US11896648utility2024
Interleukin-2 Variant Proteins Fused to Human Igg4 Fc and Uses Thereof
0 cites
US11897862utility2024
IKAROS Zinc Finger Family Degraders and Uses Thereof
0 cites
US11897878utility2024
Substituted 6-azabenzimidazole Compounds
0 cites
US11897892utility2024
Substituted Pyridotriazine Compounds and Uses Thereof
0 cites
US11883397utility2024
Substituted Pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for Treating Viral Infections
0 cites
US11878965utility2024
Inhibitors of Peptidylarginine Deiminases
0 cites
US11858918utility2024
GLP-1R Modulating Compounds
0 cites
US11851419utility2023
GLP-1R Modulating Compounds
0 cites
US11851438utility2023
1′-cyano Nucleoside Analogs and Methods for Treatment of Viral Infections
0 cites
US11845723utility2023
Diacylglycerol Kinase Modulating Compounds
0 cites
US11845737utility2023
Process for Preparing a Cot Inhibitor Compound
0 cites
US11845739utility2023
Solid Forms of an HIV Capsid Inhibitor
0 cites

← PreviousPage 7 of 11Next →